Apple Tree Partners related stories
All articles and analysis
Top ten VC deals done in Canada in 2014The Canadian Venture Capital & Private Equity Association (CVCA) and research partner Thomson Reuters will in February 2015 publish their full report on Canadian venture capital market activity in 2014. In the meantime, peHUB Canada has compiled a list of the likely top 10 (disclosed) financings completed this year.
VytronUS rakes in $31.6 mln Series BVytronUS, a Sunnyvale, Calif.-based medical device firm, has raised $31.6 million in Series B financing. The investors included Apple Tree Partners, BioStar Ventures, Windham Venture Partners and New Enterprise Associates. In addition to the funding, David McIntyre and Sami Hamade of Apple Tree Partners and Hank Kucheman of BioStar Ventures have been named to the VytronUS board of directors.
- Aileron Therapeutics grabs $33 mln Series E
Aileron Therapeutics has raised $33 million in Series E funding. The investors included AJU IB Investment Co., Apple Tree Partners, Excel Venture Management, Lilly Ventures, Novartis Venture Funds, Roche Venture Fund and SR One. Based in Cambridge, Mass., Aileron Therapeutics is a clinical stage biopharmaceutical firm that is developing therapeutics based on its proprietary Stapled Peptide drug platform.
- Dermira fetches $51 mln Series C
Dermira, a Redwood City, Calif-based maker of medical dermatology products, has closed $51 million in Series C financing. The investors included Bay City Capital, New Enterprise Associates, Canaan Partners, UCB S.A., Apple Tree Partners, Aisling Capital, Rock Springs Capital and Sabby Capital. Leerink Partners was the placement agent for the financing. In addition to the funding, Dermira has named Andrew Guggenhime as chief operating officer and chief financial officer; Christine Conroy as senior vice president of regulatory affairs; and Christine Ring as vice president of legal. It has also appointed David E. Cohen, Matthew Fust, Mark McDade and William Ringo to its board of directors.
- Cerecor closes first tranche of $32 mln Series B
Cerecor has closed on the initial tranche of a $32 million Series B funding. New Enterprise Associates, Apple Tree Partners and MPM Capital led the round. Based in Baltimore, Cerecor is a biopharmaceutical firm focused on developing treatments for patients suffering from nervous system disorders.
- Apple Tree Partners leads $25 mln Series C round in Tendyne Holdings
Apple Tree Partners has led a $25 million Series C funding round in Tendyne Holdings, Inc., a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement. Other participants in the funding round include Boulle Group members and other existing investors. David McIntyre, a partner at Apple Tree Partners, will join Tendyne's board of directors.
First quarter VC roundup - Clio’s $20 mln Series C caps solid start to the yearThe $20 million Series C financing of Clio capped a solid start to Canadian venture capital deal-making in 2014. In an interview with peHUB Canada, the startup's co-founder and CEO Jack Newton explains why the Vancouver-based provider of cloud-based tools to the legal industry is gaining traction in the marketplace. At the same time, Canadian life sciences companies have taken an especially large share of venture cash since January, suggesting that investment activity in the sector may be staging a comeback after a quiet 2013.
- First quarter VC roundup - Clio’s $20 mln Series C caps solid start to the year
The $20 million Series C financing of Clio capped a solid start to Canadian venture capital deal-making in 2014. In an interview with peHUB Canada, the startup's co-founder and CEO Jack Newton explains why the Vancouver-based provider of cloud-based tools to the legal industry is gaining traction in the marketplace. At the same time, Canadian life sciences companies have taken an especially large share of venture cash since January, suggesting that investment activity in the sector may be staging a comeback after a quiet 2013.
Top VC deals done in Canada in first quarterCanada’s Venture Capital and Private Equity Association and research partner Thomson Reuters will in May publish their full report on Canadian venture capital deal-making in the first quarter of 2014. In the meantime, peHUB Canada has compiled an early list of some of the top disclosed financings completed since January.
- Top VC deals done in Canada in first quarter
Canada’s Venture Capital and Private Equity Association and research partner Thomson Reuters will in May publish their full report on Canadian venture capital deal-making in the first quarter of 2014. In the meantime, peHUB Canada has compiled an early list of some of the top disclosed financings completed since January.